Shadi Hamoud | Heart diseases | Best Researcher Award

Posted on by ScienceFather

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

EducationπŸŽ“

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience πŸ“

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research InterestπŸ”Ž

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and HonorπŸ†

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research SkillπŸ”¬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

ConclusionπŸ’‘

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in Ξ±MUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in Ξ±MUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2

 

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Posted on by ScienceFather

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Calver Pang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over Β£146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (Β£136,080, 2019) and The Royal Free Charity Grant (Β£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (Β£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (Β£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive fundingβ€”amounting to over Β£146,000 in research grantsβ€”demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional Profile 

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

  • It Is Not All about Alkaloidsβ€”Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
    Authors: Lilo K. MailΓ€nder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.3390/plants13162208

  • Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
    Authors: Lilo K. MailÀnder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.1002/cbdv.202400159

  • Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
    Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. MailΓ€nder, Iris Klaiber, Sven Nicolay, Manuel Garcia-KΓ€ufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
    Year: 2023
    DOI: 10.3390/fermentation9020190

  • Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
    Authors: Lilo K. MailΓ€nder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2022
    DOI: 10.3390/molecules27238508

  • Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
    Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/plants10061219

  • Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
    Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/pr9050853

  • Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
    Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2021
    DOI: 10.3390/molecules26061530

  • Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, JΓΌrgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000485

  • Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, JΓΌrgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000788

 

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. πŸ₯ His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. 🌟 Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. πŸŽ“ His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. πŸ“š He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. πŸ† His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. 🌟

Professional profile

EducationπŸ“š

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional ExperienceπŸ›οΈ

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions🌐

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and RecognitionsπŸ†

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted πŸ“œ
  1. πŸ“š Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. πŸ“˜ Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571–577
    • Citations: 0
  3. πŸ“– Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791–798
    • Citations: 0
  4. πŸ“™ Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523–529
    • Citations: 0
  5. πŸ“• Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113–120
    • Citations: 0
  6. πŸ“” Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277–283
    • Citations: 0
  7. πŸ“— Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. πŸ““ Body mass index’s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370–382
    • Citations: 0
  9. πŸ“’ Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. πŸ“™ Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957–1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. πŸŽ“ His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. πŸ‘¨β€πŸ«πŸ‘©β€πŸ« Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. πŸ πŸ‘¨β€βš•οΈ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

EducationπŸ“š

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. πŸŽ“ He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. πŸ“œ Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. πŸ… Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional ExperienceπŸ›οΈ

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. πŸ’Ό His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. πŸ₯ With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟

Research Interest🌐

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. πŸ”¬ His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. πŸ₯πŸ’‘ Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. πŸ“ŠπŸ” His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟

Awards and HonorsπŸ†

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. πŸ† His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. πŸ…βœ¨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. πŸ₯πŸ‘

Research skillπŸ”¬

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. πŸ”¬ He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. πŸ“Š With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. πŸ’‘ His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. πŸ₯πŸ” His research skills contribute significantly to advancing medical science and improving surgical outcomes. πŸŒŸπŸ“ˆ

AchievementsπŸ…
  • πŸŽ“ Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • πŸ… Master’s Degree in Surgery from Nanjing Medical University
  • 🩺 Professional Certification in Surgery
  • πŸ‘¨β€βš•οΈ Completed Standard Training in clinical practice
  • 🌟 Significant Contributions to surgical techniques and patient care innovations
  • πŸ”¬ Advanced Research in surgical methods and technologies
ProjectsπŸ› οΈ
  • πŸ₯ Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • πŸ”¬ Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • πŸ“Š Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • πŸ’‘ Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • πŸ§ͺ Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
PublicationπŸ“œ
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • πŸ“ Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • πŸ“… Year: 2024
    • πŸ—žοΈ Journal: Cancer Letters
    • πŸ“ˆ Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • πŸ“ Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • πŸ“… Year: 2024
    • πŸ—žοΈ Journal: Cellular Signalling
    • πŸ“ˆ Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • πŸ“ Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Oncogene
    • πŸ“ˆ Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • πŸ“ Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Cell Metabolism
    • πŸ“ˆ Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-ΞΊB pathway in cholangiocarcinoma
    • πŸ“ Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Oncogene
    • πŸ“ˆ Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • πŸ“ Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Cancer Gene Therapy
    • πŸ“ˆ Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • πŸ“ Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: International Journal of Biological Sciences
    • πŸ“ˆ Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • πŸ“ Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: International Journal of Biological Sciences
    • πŸ“ˆ Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ΞΆ
    • πŸ“ Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • πŸ“… Year: 2022
    • πŸ—žοΈ Journal: Journal of Experimental and Clinical Cancer Research
    • πŸ“ˆ Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • πŸ“ Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • πŸ“… Year: 2022
    • πŸ—žοΈ Journal: Frontiers in Oncology
    • πŸ“ˆ Citations: 2